Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Cullinan to provide clinical data updates on three novel targeted oncology programs and complete enrollment in the pivotal Phase 2b...
Read moreCullinan to provide clinical data updates on three novel targeted oncology programs and complete enrollment in the pivotal Phase 2b...
Read moreCegeka and CTG work toward Completion of Regulatory Requirements to Complete Acquisition Cegeka and CTG signed an agreement on August 9,...
Read moreThis is the second year the Chattanooga-based business texting platform has been named to the list of fastest growing technology...
Read moreThird Quarter 2023 Financial Results -- Record quarterly net revenues of $131.8 million, representing year-over-year growth of 57.3%; net income...
Read more--Strong Q3’23 year over year (Y-O-Y) revenue growth, yield and unit cost-driven gross margin expansion and operating leverage fuel strong...
Read moreHOUSTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today announced that its...
Read moreTotal Revenue of $630.1 million and DTC Platforms Revenue of $161.0 million GAAP Net Income of $37.9 million and Credit...
Read moreRising need of road safety and traffic congestion issues in major economies. Increasing population, rapid urbanization, and globalization are factors...
Read moreRecent Portfolio Prioritization Focuses Business on Key Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline Lilly Acquires...
Read morePre-Orders Now Open for NxuOne™ EV Charging SolutionsMESA, Ariz., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Nxu Inc., (NASDAQ: NXU) (“Nxu”,...
Read more